Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for C9797. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
13
Median % of Medicare
89.9%
Rate range
$6,505.17 - $18,434.34
C9797 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $11,863.87* | 95% | -- | 2026 |
| Arizona | $11,232.08 | 89.9% | -- | 2026 |
| Kentucky | $12,190.43 | 97.6% | -- | 2026 |
| Massachusetts | $10,458.60 | 83.7% | -- | 2026 |
| Michigan | $9,795.10 | -- | -- | 2026 |
| Missouri | $16,525.03 | -- | Not required | 2026 |
| Montana | $12,488.28 | 100% | -- | 2026 |
| North Dakota | $7,186.27 | 57.5% | Not required | 2026 |
| New Mexico | $16,707.31 | -- | -- | 2026 |
| Oregon | $9,990.62* | 80% | -- | 2026 |
| Rhode Island | $18,434.34 | -- | -- | 2026 |
| Utah | $6,505.17* | 52.1% | Not required | 2026 |
| West Virginia | $11,491.78 | 92% | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 38 codes from C9047 to C9901 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for C9797?
13 state Medicaid programs publish a fee-for-service rate for C9797 (vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction), ranging from $6,505.17 in Utah to $18,434.34 in Rhode Island, with a median of 89.9% of the national Medicare amount. The full table on this page lists every publishing state's current rate.
Which state pays the most for C9797?
Rhode Island publishes the highest Medicaid rate for C9797 at $18,434.34. Utah publishes the lowest at $6,505.17.
Does C9797 require prior authorization under Medicaid?
No publishing state flags C9797 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.